These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19079168)

  • 1. IL-21 comes of age as a regulator of effector T cells in the gut.
    Fantini MC; Monteleone G; MacDonald TT
    Mucosal Immunol; 2008 Mar; 1(2):110-5. PubMed ID: 19079168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21 (IL-21) controls inflammatory pathways in the gut.
    Fina D; Caruso R; Pallone F; Monteleone G
    Endocr Metab Immune Disord Drug Targets; 2007 Dec; 7(4):288-91. PubMed ID: 18220949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-21 triggers effector cell responses in the gut.
    De Nitto D; Sarra M; Pallone F; Monteleone G
    World J Gastroenterol; 2010 Aug; 16(29):3638-41. PubMed ID: 20677335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New players in the cytokine orchestra of inflammatory bowel disease.
    Fantini MC; Monteleone G; Macdonald TT
    Inflamm Bowel Dis; 2007 Nov; 13(11):1419-23. PubMed ID: 17712836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal Immunity Related to FOXP3
    Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
    J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
    Xu XR; Liu CQ; Feng BS; Liu ZJ
    World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of a role for interleukin-13 in inflammatory bowel disease.
    Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
    Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the immunology of inflammatory bowel disease.
    MacDonald TT; Monteleone G; Pender SL
    Scand J Immunol; 2000 Jan; 51(1):2-9. PubMed ID: 10632969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
    Bates J; Diehl L
    J Pathol; 2014 Jan; 232(2):112-20. PubMed ID: 24122796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.
    Yamada A; Arakaki R; Saito M; Tsunematsu T; Kudo Y; Ishimaru N
    World J Gastroenterol; 2016 Feb; 22(7):2195-205. PubMed ID: 26900284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
    Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
    Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.